Methotrexate and Joint Pain: What the Numbers Say

Recent research has taken a close look at how methotrexate, a drug most known for treating rheumatoid arthritis, might help people with osteoarthritis. Osteoarthritis is the common joint problem that wears down cartilage and causes pain, especially in older adults. Doctors have long searched for medicines that can slow this damage, but options are limited.

What the Meta‑Analysis Showed

• Data Source: Dozens of clinical trials pooled together.
• Key Findings:
• Pain Relief: Modest improvement, but still smaller than stronger rheumatoid arthritis drugs.
• Joint Function: Slightly better outcomes in methotrexate groups.

Nutritional Concerns

Methotrexate interferes with folic acid metabolism, potentially leading to:

• Low Folate Levels: Slight increase noted in pooled data.
• Anemia Risk: No major safety concerns observed when patients received folic acid supplements.
• Overall Tolerability: Most patients tolerated the medication well.

Limitations & Future Directions

• Short‑Term Trials: Many studies had brief follow‑ups.
• Small Sample Sizes: Hard to draw firm conclusions about long‑term safety or disease modification.
• Call for Research: Larger, longer studies needed to monitor both clinical outcomes and nutritional status.

Bottom Line

Methotrexate may offer a small benefit for osteoarthritis pain, but its role remains uncertain. Patients and clinicians should weigh the modest advantages against potential nutrient effects and consider alternative treatments while awaiting clearer evidence.